We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
+23.23%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$109M
AUM Growth
-$690M
Cap. Flow
-$711M
Cap. Flow %
-651.32%
Top 10 Hldgs %
91.26%
Holding
65
New
6
Increased
2
Reduced
11
Closed
43

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$7.45M
2
ACRV icon
Acrivon Therapeutics
ACRV
+$3.61M
3
CNMD icon
CONMED
CNMD
+$2.28M
4
ISRG icon
Intuitive Surgical
ISRG
+$1.4M
5
HYPR icon
Hyperfine
HYPR
+$1.03M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$41.6M
2
A icon
Agilent Technologies
A
+$41.1M
3
BSX icon
Boston Scientific
BSX
+$37.1M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$36.7M
5
LLY icon
Eli Lilly
LLY
+$33.4M

Sector Composition

Rank Sector Weight
1 Healthcare 99.98%
2 Financials 0%

No holdings matched the selected filter criteria.

1 2 3

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q4 2022 Portfolio in Review

As of Q4 2022, HealthCor Management held 65 positions worth $109M, down 86% from $800M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

HealthCor Management withdrew a net $711M in Q4 2022, closing 43 positions and reducing 11 holdings. Its most notable exit was AbbVie, an estimated $41.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier, followed by Financials.

Against the trend, HealthCor Management opened a new position in Acrivon Therapeutics worth $3.27M.

  • HealthCor Management's largest Q4 2022 buy was Acrivon Therapeutics: 284,201 shares worth $3.27M.
  • HealthCor Management added most to DexCom in Q4 2022, an estimated $7.45M increase.
  • HealthCor Management's biggest Q4 2022 reduction was BioMarin Pharmaceuticals, cutting an estimated $36.7M.
  • HealthCor Management fully exited AbbVie in Q4 2022, selling an estimated $41.6M.
  • HealthCor Management's ten largest holdings make up 91% of its $109M portfolio in Q4 2022.
  • HealthCor Management opened 6 new positions and closed 43 in Q4 2022.
  • HealthCor Management's portfolio value fell 86% quarter-over-quarter to $109M.

Based on HealthCor Management's 13F filing for Q4 2022, filed 15 Feb 2023.